1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine has been researched along with alprenolol in 1 studies
Studies (1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine) | Trials (1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine) | Recent Studies (post-2010) (1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine) | Studies (alprenolol) | Trials (alprenolol) | Recent Studies (post-2010) (alprenolol) |
---|---|---|---|---|---|
53 | 0 | 15 | 1,146 | 121 | 59 |
Protein | Taxonomy | 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine (IC50) | alprenolol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0031 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.007 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.63 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 0.0023 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0049 | |
Squalene synthase | Rattus norvegicus (Norway rat) | 4.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bervoets, K; Mavridis, M; Millan, MJ | 1 |
1 other study(ies) available for 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and alprenolol
Article | Year |
---|---|
The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors.
Topics: Alprenolol; Animals; Apomorphine; Benzazepines; Haloperidol; Male; Motor Activity; Oxidopamine; Piperazines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Serotonin Antagonists; Substantia Nigra | 1991 |